Marco Talarico

Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework.

Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 06, 2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Journal: British journal of haematology
Published: April 26, 2026

Transition from inpatient to outpatient step-up dosing of bispecific antibodies in multiple myeloma: real-world insights.

Transition from inpatient to outpatient step-up dosing of bispecific antibodies in multiple myeloma: real-world insights.

Journal: Blood advances
Published: April 15, 2026

Concordance and prognostic value of bone-marrow MRD and PET-CT in multiple myeloma: a systematic review and meta-analysis.

Concordance and prognostic value of bone-marrow MRD and PET-CT in multiple myeloma: a systematic review and meta-analysis.

Journal: EClinicalMedicine
Published: December 01, 2025

Prospective head-to-head comparison of [18F]FDG and [⁶⁸Ga]Ga-PSMA-11 PET/CT in newly diagnosed multiple myeloma.

Prospective head-to-head comparison of [18F]FDG and [⁶⁸Ga]Ga-PSMA-11 PET/CT in newly diagnosed multiple myeloma.

Journal: European journal of nuclear medicine and molecular imaging
Published: November 25, 2025

Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.

Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.

Journal: Frontiers in oncology
Published: July 24, 2025

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going.

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going.

Journal: Blood advances
Published: May 07, 2025

T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.

T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.

Journal: Cancers
Published: February 20, 2025

Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.

Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.

Journal: Clinical and experimental medicine
Published: February 17, 2025

Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma.

Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma.

Journal: Expert opinion on biological therapy
Published: December 09, 2024

Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.

Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.

Journal: Expert review of anticancer therapy
Published: May 27, 2024

Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review.

Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 13, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026